08.11.2014 Views

Here - American Geriatrics Society

Here - American Geriatrics Society

Here - American Geriatrics Society

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

P OSTER<br />

A BSTRACTS<br />

The oldest old (age>85yo) are the fastest growing segment of<br />

the US population<br />

About 27% of Medicare’s annual $426 billion budget goes to<br />

care for patients in their final year of life, with acute hospitalizations<br />

being a major cost.<br />

Evidence supports improved clinical and utilization outcomes<br />

with palliative care consults for seriously ill patients and increased<br />

patient and family satisfaction.<br />

The goal of this study was to assess the role of palliative care<br />

consults(PCC)in preventing futile escalation of care in a cohort of seriously<br />

ill oldest old inpatients.<br />

Methods:<br />

A retrospective chart review of palliative care consults in a tertiary<br />

academic medical center between August 2008 and June 2011<br />

yielded 314 patients >85 yo. Charts were reviewed to extract patient<br />

demographics,admitting diagnosis, inpatient mortality and disposition<br />

post PCC including initiation of “Do Not Escalate Care” pathway<br />

and facilitation of Hospice discharge.<br />

Results:<br />

-Of the 314 patients identified, there were 148 males (47%) and<br />

166 females (53%).153 patients (49%) were nonagenarians.<br />

-Admission diagnosis included Cancer: 25% (77), Stroke:15%<br />

(48), Cardiac:15% (47), Dementia: 12% (36), Pulmonary: 6% (8), and<br />

Other (including infection, falls, failure to thrive, Hepatic & Renal<br />

disease): 27% (86)<br />

-36% (113 patients) died during the course of hospitalization.<br />

-PCC resulted in the initiation of the “Do Not Escalate Care”<br />

pathway in 73% (229 patients) during the hospitalization.<br />

-Of the 201 patients who did not die during the hospitalization,hospice<br />

was initiated in 60% (113 patients): 32% home hospice,<br />

22% long term care facility with hospice, 6% inpatient hospice. Non<br />

hospice discharges: 17% SNF and 18% home. No discharge data<br />

available: 5%.<br />

Conclusions:<br />

-Oldest old inpatients had a high (36%) in hospital mortality.<br />

Most deaths were expected and due to serious illnesses including<br />

Cancer, Stroke, end stage cardiac, lung and renal disease.<br />

-PCC resulted in initiation of the “Do Not Escalate Care” pathway<br />

in 73% of the patients, thereby preventing ineffective interventions<br />

(such as CPR, invasive procedures, ICU care) in this seriously ill<br />

population of older adults;<br />

-PCC facilitated discharge to hospice in 60% of the survivors,<br />

thereby promoting comfort and quality of life while avoiding prolonged<br />

hospitalizations.<br />

B148<br />

Predicting Mortality in End Stage Dementia: A Retrospective<br />

comparison of Medicare Guidelines and Mitchell Criteria for<br />

Hospice Referral.<br />

J. Almeida, M. C. Galicia-Castillo. Internal Medicine/<strong>Geriatrics</strong>,<br />

Eastern Virginia Medical School, Norfolk, VA.<br />

Background: Dementia is the sixth-leading cause of death posing<br />

a significant cost of $183 billion annually(1). The progression of<br />

the disease is variable, with the end stage lasting as long as three<br />

years(2). Current guidelines for predicting six-month mortality have<br />

been under scrutiny; they are not evidenced-based and were never<br />

studied prior to implementation as hospice criteria(3,4). Mitchell et al<br />

derived a mortality risk index for six-month mortality using items<br />

from the minimum data set. The objective of this study was to compare<br />

the Mitchell risk index to Medicare guidelines in predicting sixmonth<br />

mortality in end-stage dementia(3).<br />

Methods: A retrospective chart review of patients who died<br />

from dementia in a nursing home facility from January 2004 through<br />

December of 2009 was performed. Data points from three, six and<br />

twelve months prior to death were collected from the minimum data<br />

set. At each point subjects were coded as eligible or ineligible for hospice<br />

according to Mitchell risk index and Medicare guidelines.<br />

Results: At six months prior to death, out of 24 subjects, the<br />

Mitchell risk index score identified 13 (54%) as eligible for hospice<br />

and Medicare guidelines identified six(25%; p =0.16). Three months<br />

prior to death, out of 24 subjects Mitchell risk index identified 19<br />

(79%); using Medicare guidelines identified nine(37.5%, p=0.118)<br />

Conclusion: Current guidelines for predicting six-month mortality<br />

for appropriate hospice referral for end-stage dementia are inaccurate.<br />

The Mitchell risk index may be a better tool to help clinicians<br />

better prognosticate six-month mortality and employ hospice services<br />

earlier.<br />

References<br />

1 Herbert, LE; Scherr, PA; Bienias, JL; Bennet, DA. Alzheimer<br />

Disease in the U.S. Population: Prevalence Estimates Using the 2000<br />

Census. Archives of Neurology August 2003:60(8)1119-1122.<br />

2 Shuster, J. Palliative Care for Advanced Dementia. Clinics in<br />

Geriatric Medicine 2000: 16(2).<br />

3 Mitchell, SL; Kiely, DK; Hamel, MB; Park, PS; Morriss, JN;<br />

Fries, BE. Estimating Prognosis for Nursing Home Residents with<br />

Advanced Dementia. JAMA2004:291 (22) 2734-2740.<br />

4 Schonwetter RS, Han B, Small BJ, Martin B, Tope K, Haley<br />

WE. Predictors of six-month survival among patients with dementia.<br />

<strong>American</strong> Journal of Hospice and Palliative Care 2003:(20):105-113.<br />

B149 Encore Presentation<br />

Pain is good for you? Non-cancer pain predicts improved 5-year<br />

survival.<br />

J. Shega, 1 M. Andrew, 2 D. Lau, 3 K. Herr, 4 M. Ersek, 5 D. Weiner, 6<br />

W. Dale. 1 1. Medicine, University of Chicago, Chicago, IL; 2.<br />

Medicine, Dalhousie University, Halifax, NS, Canada; 3. Pharmacy,<br />

University of Illinois, Chicago, IL; 4. Nursing, University of Iowa, Des<br />

Moines, IA; 5. Nursing, University of Pennsylvania, Philidelphia, PA;<br />

6. Medicine, University of Pittsburgh, Pittsburgh, PA.<br />

Supported By: NIA<br />

Background: Non-cancer pain is known to result in significant<br />

morbidity, but little is known about its impact on mortality. We assessed<br />

the relationship of self-reported non-cancer pain at baseline<br />

and subsequent 5-year mortality among community-dwelling older<br />

adults.<br />

Methods: We analyzed data from a large prospective cohort<br />

study, the 1996 wave of the Canadian Study of Health and Aging.<br />

Non-cancer pain was assessed using the 5-point verbal descriptor<br />

scale, dichotomized into “no/very mild” versus “moderate” or greater<br />

pain. Frailty was measured as the sum of self-reported health (1<br />

item), social support (1 item), co-morbidity (17 items), and functional<br />

abilities (14 items) with each item scored from 0 to 1, ranging from 0-<br />

33, with higher scores indicating greater frailty. Cognitive status was<br />

measured using the Modified Mini-Mental Status Exam, ranging<br />

from 0-100, with a score 11<br />

indicating depression. Multivariable logistic regression was used to<br />

analyze the relationship between pain and mortality, controlling for<br />

other factors.<br />

Results: Of the 5,703 participants, 4,694 (82.3%) had complete<br />

data for analysis. Of these, 35.4% reported moderate or greater pain<br />

and 28.6% had died at 5-year follow-up. The 5-year mortality odds<br />

increased by 1.12 (CI: 1.10, 1.13); p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!